Trends in the incidence and survival of multiple myeloma in South East England 1985-2004

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Renshaw, Christine ^a   Ketley, Nicolas ^b   Møller, Henrik ^a   Davies, Elizabeth A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NATIONAL HEALTH SERVICE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER SURVIVAL; CHILD; DATA BASE; ETHNICITY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; OVERALL SURVIVAL; QUALITY OF LIFE; SEX DIFFERENCE; SOCIAL STATUS; SURVIVAL RATE; TREND STUDY; UNITED KINGDOM; INCIDENCE; MIDDLE AGED; MORTALITY; ONCOLOGY; REGISTER; SEX RATIO; SOCIOECONOMICS; TIME;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ENGLAND; FEMALE; HUMANS; INCIDENCE; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; MULTIPLE MYELOMA; REGISTRIES; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; TIME FACTORS;

EID: 77950281641     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-74     Document Type: Article

References (23)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics 2001. CA Cancer J Clin 2001, 51:15-36. 10.3322/canjclin.51.1.15, 11577478.
2. George ED, Sadovsky R. Multiple myeloma: Recognition and management. Am Fam Physician 1999, 59:1885-1897.
3. Smith A, Wisloff F, Samson D. Guidelines on the diagnosis and management of multiple myeloma 2005. Br J Haematol 2005, 132:410-451.
4. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG, Edwards BK, . (eds) 2009, SEER Cancer Statistics Review, 1975-2006, National Cancer Institute. Bethesda, MD, based on November 2008 SEER data submission, posted to the SEER web site, (eds)., http://seer.cancer.gov/csr/1975_2006/
5. National Cancer Intelligence Network Cancer incidence and survival by ethnic group, England 2002-2006. National Cancer Intelligence Network., http://www.ncin.org.uk/docs/090625-NCIN-Incidence_and_Survival_by_Ethnic_Group-Report.pdf
6. Office for National Statistics, Cancer statistics registrations: registrations of cancer diagnosed in 2006, England Series MB1 no.35. 2007,
7. Alexander DD, Mink PJ, Adami H-O, Cole P, Mandel JS, Oken MM, Trichopoulos D. Multiple myeloma: A review of the epidemiology literature. Int J Cancer 2007, 120:40-61. 10.1002/ijc.22718, 17405120.
8. Huang S-Y, Yao M, Tang J-L, Lee W-C, Tsay W, Cheng A-L, Wang C-H, Chen Y_C, Shen M-C, Tien H-F. Epidemiology of multiple myeloma in Taiwan: increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years. Cancer 2007, 110:896-905. 10.1002/cncr.22850, 17594697.
9. Møller H, Fairley L, Coupland V, Okello C, Green M, Forman D, Møller B, Bray F. The future burden of cancer in England: Incidence rates and numbers of new patients in 2020. Br J Cancer 2007, 96:1484-1488. 10.1038/sj.bjc.6603746, 2360166, 17473821.
10. Quinn M, Babb P, Brock A, Kirky L, Jones J. Cancer trends in England and Wales 1950-1999. Studies on Medical and Population Subjects 2001, 66. London, The stationary office.
11. Kristinsson SY, Landgren O, Dickman P, Derolf AR, Björkhom M. Patterns of survival in Multiple Myeloma: A population-based study of patients diagnosed in Sweden from 1973 to 2003. J Clin Oncol 2007, 25:993-1999.
12. Phekoo KJ, Schey SA, Richards MA, Bevan DH, Bell S, Gillet D, Moller H. A population study to define the incidence and survival of multiple myeloma in a National Health Service Regional in UK. Br J Haematol 2004, 127:299-304. 10.1111/j.1365-2141.2004.05207.x, 15491289.
13. Rachet B, Mitry E, Shah A, Cooper N, Coleman MP. Survival from multiple myeloma in England and Wales up to 2001. Br J cancer 2008, 99(S1):110-112. 10.1038/sj.bjc.6604607, 2453030, 18577984.
14. Brenner H, Gefeller O. An alternative approach to monitoring cancer patients survival. Cancer 1996, 78:2004-2010. 10.1002/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO;2-#, 8909323.
15. Neighbourhood Renewal Unit The English Indices of deprivation 2004: Summary (revised) 2004, London, Office of the Deputy Prime Minister, Neighbourhood Renewal Unit.
16. Brenner H, Gondos A, Pulte D. Recent major improvement in long-term survival of younger patients with multiple myeloma. Blood 2008, 111:2521-2526. 10.1182/blood-2007-08-104984, 17901246.
17. Ludwig H, Durie BGM, Bolejack V, Turesson I, Kyle RA, Blade J, Fonseca R, Dimopoulos M, Shimizu K, San Miguel J, Westin J, Harousseau J-L, Beksac M, Boccadoro M, Palumbo A, Barlogie B, Shustik C, Cavo M, Greipp PR, Josshua D, Attal M, Sonnevald P, Crowley P. Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10549 patients from the International Myeloma Working Group. Blood 2008, 111:4039-4047. 10.1182/blood-2007-03-081018, 18268097.
18. Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Zeldenrust SR, Dingli D, Russell SJ, Lust JA, Greipp PR, Kyle RA, Gertz MA. Improved survival in multiple myeloma and the impact of novel therapies. Blood 2008, 111:2516-2520. 10.1182/blood-2007-10-116129, 2254544, 17975015.
19. Barlogie B, Shaughnessy J, Tricot G, Jacobson J, Zangari M, Anaissie E, Walker R, Crowley J. Treatment of multiple myeloma. Blood 2004, 103:20-32. 10.1182/blood-2003-04-1045, 12969978.
20. Richardson P, Mitsiades C, Schlossman R, Ghobrail I, Hideshima T, Chauhan D, Munshi N, Anderson K. The treatment of relapsed and refractory multiple myeloma. Hematology Am Soc Hematol Educ Program 2007, 317-323.
21. Schey S. Survival from multiple myeloma in England and Wales up to 2001. Br J Cancer 99(S1):113-115.
22. Harousseau J-L. Induction therapy in multiple myeloma. Hematology Am Soc Hematol Educ Program 2008, 306-312.
23. Gebregziabher M, Bernstein L, Wang Y, Cozen W. Risk patterns of multiple myeloma in Los Angeles County, 1972-1999 (United States). Cancer causes Control 2006, 17:931-938. 10.1007/s10552-006-0030-x, 16841260.